First Hawaiian Bank’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-11,265
Closed -$1.48M 156
2024
Q4
$1.48M Buy
11,265
+4,257
+61% +$596K 0.05% 314
2024
Q3
$1.09M Sell
7,008
-354
-5% -$57.1K 0.03% 398
2024
Q2
$1.15M Buy
7,362
+492
+7% +$74K 0.04% 336
2024
Q1
$931K Sell
6,870
-427
-6% -$56.5K 0.03% 424
2023
Q4
$983K Sell
7,297
-179
-2% -$23.3K 0.03% 392
2023
Q3
$1.01M Buy
7,476
+62
+0.8% +$8.47K 0.03% 370
2023
Q2
$1.06M Buy
7,414
+56
+0.8% +$8.24K 0.03% 364
2023
Q1
$1.02M Buy
7,358
+160
+2% +$21.5K 0.03% 364
2022
Q4
$977K Sell
7,198
-210
-3% -$26.3K 0.04% 362
2022
Q3
$813K Buy
7,408
+296
+4% +$37.6K 0.03% 383
2022
Q2
$940K Buy
7,112
+547
+8% +$71.8K 0.03% 365
2022
Q1
$870K Buy
6,565
+1,826
+39% +$219K 0.03% 430
2021
Q4
$552K Buy
+4,739
New +$558K 0.02% 598
2019
Q2
Sell
-768
Closed -$63K 831
2019
Q1
$63K Hold
768
﹤0.01% 992
2018
Q4
$58K Hold
768
﹤0.01% 1025
2018
Q3
$60K Buy
+768
New +$58.1K ﹤0.01% 1094
2013
Q3
Sell
-569
Closed -$27K 176
2013
Q2
$27K Buy
+569
New +$29K 0.01% 480

Other funds holding AZN

First Hawaiian Bank's AZN Position: Q1 2025 in Review

First Hawaiian Bank sold out of AstraZeneca (AZN) in Q1 2025, closing a stake of 11,265 shares — an estimated $1.48M sold.

First Hawaiian Bank first reported a position in AZN in Q2 2013 and held it in 17 quarters. The position peaked at $1.48M in Q4 2024. 1,251 funds tracked by Wall St. Rank hold AZN as of Q1 2025.

  • First Hawaiian Bank reported no remaining AstraZeneca position as of Q1 2025 after selling out during the quarter.
  • First Hawaiian Bank sold 11,265 AstraZeneca shares in Q1 2025, an estimated $1.48M.
  • First Hawaiian Bank first reported a position in AstraZeneca in Q2 2013 and held it in 17 quarters.
  • First Hawaiian Bank's AstraZeneca position peaked at $1.48M in Q4 2024.
  • 1,251 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2025.

Based on First Hawaiian Bank's 13F filing for Q1 2025, filed 3 Apr 2025.